UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 98-1340767 (State or other jurisdictio ...

Company Participants Mathew Blackman - Stifel Senior Director of Investor Relations, Alexa Huerta, you may begin the conference. We do not undertake any obligation to revise or update such forward-looking statements. Some factors that could cause actual results to be materially different from the forward-looking statements made by us on the call include the risk factors disclosed under the heading Risk Factors in our Form 10-K for the year ended December 31, 2022 and Form 10-Q filed this afternoon, May 9, 2 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 98-1340767 (State or other jurisdicti ...

John Bostjancic Thanks, Keith, and good afternoon everyone. As Keith noted earlier, SeaSpine's total revenue for the fourth quarter of 2022 was $63.4 million, a 14% increase over the prior year. In the U.S. we posted 16% growth. The U.S. spinal implant and enabling technologies revenue in the fourth quarter increased 12%. Within that category, U.S. spinal implant revenue increased by more than 23%. Products launched or enhanced via line extensions within the past five years continue to grow revenue and acco ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 98-1340767 (State or other jurisdiction of (I.R.S. Em ...

On October 11, 2022 Orthofix and SeaSpine announced an agreement to merge that is expected to close in the first quarter of 2023. Please also view the presentation and press release describing the merger, which are both posted on our website. 1 ORTHOFIX Improving patient mobility through innovation Forward-Looking Statements and Non-GAAP Financial Measures 2 2 Except for historical information contained herein, the statements made in this presentation constitute forward-looking statements that involve certa ...

Orthofix Medical, Inc. (NASDAQ:OFIX) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Alexa Huerta - Senior Director, IR Jon Serbousek - President, CEO & Director Douglas Rice - CFO & CAO Conference Call Participants David Turkaly - JMP Securities Mathew Blackman - Stifel, Nicolaus & Company Jeffrey Cohen - Ladenburg Thalmann & Co. James Sidoti - Sidoti & Company Operator Good morning. My name is Gavin and I will be your conference operator today. At this time, I would like ...

ORTHOFIX® 1 Improving patient mobility through innovation Forward-Looking Statements and Non-GAAP Financial Measures 2 2 Except for historical information contained herein, the statements made in this presentation constitute forward-looking statements that involve certain risks and uncertainties. These forward-looking statements are based on our beliefs and expectations as of August 5, 2022, and we do not undertake any obligation to revise or update such forward looking statements, which speak only as of su ...

Orthofix Medical Inc. (NASDAQ:OFIX) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Alexa Huerta – Senior Director-Investor Relations Jon Serbousek – President and Chief Executive Officer Doug Rice – Chief Financial Officer Conference Call Participants Mathew Blackman – Stifel Jeffrey Cohen – Ladenburg Jim Sidoti – Sidoti and Company Operator Hello, and a warm welcome to Orthofix MedicalÂ's Q2 2022 Earnings Call. My name is Melissa, and IÂ'll be your operator today. [Operator ...

Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Jon Serbousek – Director, President and Chief Executive Officer Doug Rice – Chief Financial Officer Alexa Huerta – Senior Director of Investor Relations and Finance Conference Call Participants Mathew Blackman – Stifel Financial Corp. Jeffrey Cohen – Ladenburg Thalmann & Co. Inc. Jim Sidoti – Sidoti & Company, LLC Operator Good morning, everyone and welcome to today's Orthofix Medical First Quart ...